Cannara Secures 5 Key Listings in Québec’s New Vape Cartridge Category Including to be Released Live Rosin Vapes
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 23 2025
0mins
Should l Buy ?
Source: Globenewswire
Cannara Biotech's Product Launch: Cannara Biotech Inc. has received preliminary acceptance from the Société Québécoise du Cannabis for five vape cartridge products, set to be distributed in Québec retail stores and online starting November 2025, marking a significant entry into the province's cannabis market.
Market Potential and Innovations: The launch includes live resin and live rosin vape cartridges, with Cannara aiming to leverage its R&D capabilities to provide premium-quality products without additives, tapping into a growing consumer base as the vape segment represents a substantial opportunity in Canada's legal cannabis market.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
